Abstract According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is
the 6th primary cause of death in the USA, which affects nearly 5.5 million people. In the …

Thanks to its safety and accessibility, magnetic resonance imaging (MRI) is extensively used
in clinical routine and research field, largely contributing to our understanding of the …

Alzheimer's disease is an incurable, progressive neurological brain disorder. Earlier
detection of Alzheimer's disease can help with proper treatment and prevent brain tissue …

Abstract In conventional Magnetic Resonance (MR) image based methods, two stages are
often involved to capture brain structural information for disease diagnosis, ie, 1) manually …

In the field of computer-aided Alzheimer's disease (AD) diagnosis, jointly identifying brain
diseases and predicting clinical scores using magnetic resonance imaging (MRI) have …

Background Mild cognitive impairment (MCI) due to Alzheimer's disease is the symptomatic
predementia phase of Alzheimer's disease dementia, characterised by cognitive and …

Accurate diagnosis of Alzheimer's disease (AD) and its prodromal stage mild cognitive
impairment (MCI) is of great interest to patients and clinicians. Recent studies have …

Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing,
longitudinal, multicenter study designed to develop clinical, imaging, genetic, and …

Background Hippocampus is one of the first structures affected by neurodegenerative
diseases such as Alzheimer's disease (AD) and mild cognitive impairment (MCI) …

Machine learning algorithms and multivariate data analysis methods have been widely
utilized in the field of Alzheimer's disease (AD) research in recent years. Advances in …